Silvia Pecere

InstitutionFondazione Policlinico Universitario A Gemelli IRCCS
AddressRome
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 3 Covid-19 publications, with a maximum of 1 publications in June 2020 and Spetember 2020 and February 2021
    All Publications
    Bar chart showing 18 publications over 7 distinct years, with a maximum of 5 publications in 2015
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pecere S, Barbaro F, Petruzziello L, Papparella LG, Napoli M, Boskoski I, Costamagna G. Outpatient ESD for challenging colorectal lesions: Is it feasible and safe for western countries? Endosc Int Open. 2021 Mar; 9(3):E438-E442. PMID: 33655047.
      Citations:    
    2. Furnari M, Eusebi LH, Savarino E, Petruzzellis C, Esposito G, Maida M, Ricciardiello L, Pecere S, Buda A, De Bona M, Spada C, Di Giulio E, Costamagna G, Boskoski I, Giannini EG. Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study. Gut. 2021 07; 70(7):1241-1243. PMID: 32989018.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Boškoski I, Pecere S, Bove V, Barbaro F, Perri V, Costamagna G. Impact of SARS-CoV-2 on a high volume endoscopy center in Italy. Dig Liver Dis. 2020 08; 52(8):819-822. PMID: 32593516.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    4. Pecere S, Costamagna G. Endoscopic therapy for confirmed low-grade dysplasia in Barrett's esophagus. Transl Gastroenterol Hepatol. 2018; 3:83. PMID: 30505970.
      Citations:    
    5. Eliakim R, Spada C, Lapidus A, Eyal I, Pecere S, Fernández-Urién I, Lahat A, Costamagna G, Schwartz A, Ron Y, Yanai H, Adler S. Evaluation of a new pan-enteric video capsule endoscopy system in patients with suspected or established inflammatory bowel disease - feasibility study. Endosc Int Open. 2018 Oct; 6(10):E1235-E1246. PMID: 30302381.
      Citations: 12     
    6. Pecere S, Holleran G, Ainora ME, Garcovich M, Scaldaferri F, Gasbarrini A, Zocco MA. Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). Dig Liver Dis. 2018 Aug; 50(8):761-767. PMID: 29705029.
      Citations: 5     Fields:    Translation:Humans
    7. Scaldaferri F, D'Ambrosio D, Holleran G, Poscia A, Petito V, Lopetuso L, Graziani C, Laterza L, Pistone MT, Pecere S, Currò D, Gaetani E, Armuzzi A, Papa A, Cammarota G, Gasbarrini A. Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575. PMID: 29073159.
      Citations: 8     Fields:    Translation:Humans
    8. Holleran G, Lopetuso LR, Ianiro G, Pecere S, Pizzoferrato M, Petito V, Graziani C, McNAMARA D, Gasbarrini A, Scaldaferri F. Gut microbiota and inflammatory bowel disease: so far so gut! Minerva Gastroenterol Dietol. 2017 Dec; 63(4):373-384. PMID: 28293937.
      Citations: 11     Fields:    Translation:Humans
    9. Ponziani FR, Pecere S, Lopetuso L, Scaldaferri F, Cammarota G, Gasbarrini A. Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation. Expert Opin Drug Saf. 2016 Jul; 15(7):983-91. PMID: 27149541.
      Citations: 5     Fields:    Translation:Humans
    10. Cammarota G, Pecere S, Ianiro G, Masucci L, Currò D. Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases. Dig Dis. 2016; 34(3):279-85. PMID: 27027524.
      Citations: 9     Fields:    Translation:Humans
    11. Ponziani FR, Scaldaferri F, Petito V, Paroni Sterbini F, Pecere S, Lopetuso LR, Palladini A, Gerardi V, Masucci L, Pompili M, Cammarota G, Sanguinetti M, Gasbarrini A. The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. Dig Dis. 2016; 34(3):269-78. PMID: 27027301.
      Citations: 33     Fields:    Translation:HumansCells
    12. Ianiro G, Pecere S, Giorgio V, Gasbarrini A, Cammarota G. Digestive Enzyme Supplementation in Gastrointestinal Diseases. Curr Drug Metab. 2016; 17(2):187-93. PMID: 26806042.
      Citations: 15     Fields:    Translation:HumansAnimals
    13. Minordi LM, Scaldaferri F, Marra RS, Pecere S, Larosa L, Poscia A, Gasbarrini A, Vecchioli A, Bonomo L. Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy. Eur J Radiol. 2016 Feb; 85(2):404-13. PMID: 26781146.
      Citations: 3     Fields:    Translation:Humans
    14. Ponziani FR, Gerardi V, Pecere S, D'Aversa F, Lopetuso L, Zocco MA, Pompili M, Gasbarrini A. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. World J Gastroenterol. 2015 Nov 21; 21(43):12322-33. PMID: 26604640.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    15. Ponziani FR, Pecere S, Gasbarrini A, Ojetti V. Physiology and pathophysiology of liver lipid metabolism. Expert Rev Gastroenterol Hepatol. 2015; 9(8):1055-67. PMID: 26070860.
      Citations: 26     Fields:    Translation:HumansAnimals
    16. Ianiro G, Bibbò S, Pecere S, Gasbarrini A, Cammarota G. Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease. Comput Biol Med. 2015 Oct 01; 65:308-14. PMID: 25982198.
      Citations:    Fields:    Translation:Humans
    17. Fagiuoli S, Ravasio R, Lucà MG, Baldan A, Pecere S, Vitale A, Pasulo L. Management of hepatitis C infection before and after liver transplantation. World J Gastroenterol. 2015 Apr 21; 21(15):4447-56. PMID: 25914454.
      Citations: 7     Fields:    Translation:HumansCells
    18. Scaldaferri F, Pizzoferrato M, Pecere S, Forte F, Gasbarrini A. Bacterial flora as a cause or treatment of chronic diarrhea. Gastroenterol Clin North Am. 2012 Sep; 41(3):581-602. PMID: 22917165.
      Citations: 3     Fields:    Translation:HumansCells